or
.endmg 31
& Accounts
March 2022.
tenovQ
Registered Company No. 00943501
IRegialered Charity No.1054015
cancer care
gofal cctnser
##
|Contents|Contents||||||
|---|---|---|---|---|---|---|
|Chair and Chief Executive's||Introduction|||||
|Trustees' Report (Incorporating|||Directors' and Strategic Reports)||||
|What we achieved|||||||
|Support Line|||||||
|Benefits service|||||||
|Tele-friend|||||||
|CounseLLing|||||||
|Sing with Us Choirs|||||||
|Mobile Support Units|||||||
|Pressing for a better deal for people affected by cancer||||||11|
|Advocacy and Campaigning||||||12|
|Less survivable
cancers||||||12|
|Research||||||14|
|We couldn't do itwithout||you||||15|
|Our Income in 2021/22||||||17|
|Developing
new ways ofraising||||money||19|
|Adapting
existing opportunities||||||19|
|Breast Cancer Awareness||Month||||19|
|Corporate
partnerships||||||19|
|Individual
Giving||||||19|
|Regional Fundraising||||||20|
|ChaLlenge
Events and Special Events||||||21|
|Trusts and Foundations||||||22|
|Gifts in WilLs||||||22|
|Retail||||||23|
|Supporting
our people||||||25|
|Money spent on support services||||2021/22||29|
|Looking forward|||||||
|Structure, Governance|and|Management||||33|
|Policies||||||41|
|Statement ofTrustees'|Responsibilities||||for the FinanciaL Statements|42|
|and Corporate Governance|||||||
|Independent
Auditors'|report to|||the members ofTenovus Cancer Care||43|
|Financial Statements||||||46|
|Notes to the financial statements||||for the year ended 31March 2022||51|
|Wewant tothank||||||81|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|C(Chair
~Committee/
Sub Committee/
Group Member|||t'
E
E|In
tu
'o.|In
tu
'o.|IIJ
Ie
tu
Irlel
Iog||cco0
cs
Ja
Ill|
|---|---|---|---|---|---|---|---|---|
||||U|||||IJ|
|||IJ EE
«0
u U||«U||I/I|ore E
E~E|reel
Ql|
|Trustees|||||||||
|PrOf MalCOlm
MaSOn (Chairman)||Standing
Invite|Standing
Iraate||||||
|Michael Borrill loeputy chair)|||||||||
|Anne-Marie
Koukourava|||||||||
|Prof Geraint WILL(ams|||||||||
|Prof Deborah Fitzsimmons|||||||||
|(Resigned 21"September 2021)|||||||||
|Hugh O' Sullivan|~|~|||||||
|Christopher
Thomson|~|~|||||||
|Timothy Finch|||||||||
|Prof Peter Barrett Lee|||||||||
|Louise FLeet|||||||||
|Huw George|~|~|||||||
|Chief Executive||Judi Rhys MBE|
|---|---|---|
|Director ofFinance||Hazel Sweeney FCA CTA|
|Director ofIncome Generation||Darren Irwin|
|Director ofPeople ik|Development|Julie Rees|
|Director ofMarketing|8t Communications|James Powell|
|||(unti( 22M October 2021)|
|Director of Support,|Policy and Insight|Lowri Griffiths
(appointed
25~ April 2022)|
|Company|Secretary|Hazel Sweeney FCA CTA||
|---|---|---|---|
|Principal|Address and Registered Office|I"Floor, Jones Court, Womanby|Street,|
|||Cardiff CF10 1BR.||
|||Telephone: 0292076 8850||
|Principal Professional|Principal Professional|Advisors and|Azets Audit Services Ty Derw,|
|---|---|---|---|
|External Auditors|||Lime Tree Court, Cardiff Gate|
||||Business Pttrk, Cardiff CF23 8AB.|
|Solicitors|||Berry Smith, Haywood
House,|
||||Dumfries Place, Cardiff CF103GA.|
|Bankers|||HSBCBank pic, 56Queen Street,|
||||Cardiff CF104PX|
|Investment|Advisors||Barclays Wealth,
2"0Floor,|
||||Windsor Court, 1-3Windsor Place,|
||||Cardiff CF103BX|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Designated
Funds||
|---|---|
|Community
Insight and Emotional Support|200,000|
|Increased
DigitaUsation
across the Charity-|98,357|
|added a further E50,000for future spend||
|Lung Cancer Screening
Implementation
added 800,000|200,000|
|Retail Improvement
Programme
added 839,022|330,000|
|Less Survivable
Cancers newly created|100,000|
|End ofLife Benefits Work and Support newly created|100,000|
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Note|Unrestricted|Restricted|Funds|Total 2022|Total 2021|
|---|---|---|---|---|---|---|---|
||||Funds 2022|2022||||
||||E|E||||
|INCOME &||||||||
|ENDOWMENTS|FROM:|||||||
|Donations
8|||1,800,228||564,016|2,364,244|3,560,657|
|Legacies||||||||
|Charitable
Activities||3|||||61,931|
|Total Fundraising|||1,800,228||564,016|2,364,244|3,622,588|
|Income||||||||
|Expenditure||||||||
|Raising funds—|||1,148,678||5,522|1,154,200|1,158,694|
|donations
&||||||||
|legacies||||||||
|Total Fundraising|||1,148,678||5,522|1,154,200|1,158,694|
|Expenditure||||||||
|Fundraising|||651,550||558,494|1,210,044|2,463,894|
|Contribution||||||||
|Job Retention|||||36,512|36,512|1,250,012|
|Scheme||||||||
|Covid Retail Grants|||289,883|||289,883|1,032,143|
|Investment
income||5|103,752|||103,752|45,440|
|Other income|||8,451|||8,451||
|Total Contribution|||1,053,636||595,006|1,648,642|4,791,489|
|from Income &||||||||
|Endowments||||||||
|Retail Operations|||5,034,469|||5,034,469|1,585,340|
|Trading
Income||||||||
|Retail Operations||7|(4,293,876)||(28,114)|(4,321,990)|3,722,295|
|Trading
Expenditure||||||||
|Contribution
from|||740,593||(28,114)|712,479|(2,136,955)|
|Retail Operations||||||||
|Other Trading|||678,704||1,114|679,818|603,165|
|Activities Income||||||||
|Other Trading|||(212,303)|||(212,303)|261,313|
|Activities||||||||
|Expenditure||||||||
|Contribution
from|||466,401||1,114|467,515|341,852|
|Other Activities||||||||
|Total Contribution|||1,206,994||(27,000)|1,179,994|(1,795,103)|
|from Trading||||||||
|Activities||||||||
|||||Group||Charity||
|---|---|---|---|---|---|---|---|
||||Note|2022|2021|2022|2021|
|||||6||6||
|FIXEDASSETS||||||||
|Tangible assets|||14|1,252,833|1,543,457|1,252,833|1,543,457|
|Intangible
assets|||15|106,280|76,268|106,280|76,268|
|Investments|||16|4,609,783|4,022,759|4,609,783|4,022,759|
|||||5,968,896|5,642,484|5,968,896|5,642,484|
|CURRENT ASSETS||||||||
|Stock|||17|9,017|58,789|||
|Debtors|||18|888,110|717,419|1,004,548|805,047|
|Cash at bank and|in|hand||1,881,962|1,048,822|1,709,086|959,555|
|||||2,779,089|1,825,030|2,713,634|1,764,602|
|CURRENT LIABILITIES||||||||
|Creditors:
amounts||falling|19|(1,082,898)|(1,137,707)|(1,024,794)|(1,084,630)|
|due within one year||||||||
|NET CURRENT||||1,696,191|687,323|1,688,840|679,972|
|ASSETS/(LIABILITIES)||||||||
|Creditors:
amounts||falling||(162,449)|(303,712)|(162,449)|(303,712)|
|due more than one year||||||||
|TOTAL NET ASSETS||||7,502,638|6,026,095|7,495,287|6,018,744|
|FUNDS||||||||
|Unrestdicted||||||||
|Parent charity|||21|6,417,888|4,978,329|6,417,888|4,978,329|
|Subsidiary
Company|||21|7,351|7,351|||
|Total unrestricted|funds||21|6,425,239|4,985,680|6,417,eee|4,978,329|
|Restricted|||21|1,077,399|1,040,415|1,077,399|1,040,415|
|||||7,502,638|6,026,095|7,495,287|6,018,744|
##
||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|
||||||||6|6|
|CASH FLOWS FROM OPERATING|ACTIVITIES||||||||
|Net cash provided/
(used in) operating||activities|||||1,006,031|1,297,916|
|(Noted on Page 50)|||||||||
|CASH FLOWS FROM INVESTING|ACTIVITIES;||||||||
|Interest received|||||||10|4|
|Dividends
from investments|||||||103,742|45,436|
|Dividends
re-invested||||||||17,034|
|Proceeds from sale ofinvestments|||||||611,893|1,961,286|
|Proceeds from sale offixed assets|||||||126,670|93,633|
|Foreign exchange gains/losses|||||||4,300|946|
|Purchase oftangible
and intangible|assets||||||(76,361)|(51,107)|
|Purchase ofinvestments|||||||(928,852)|(2,234,127)|
|NET CASH PROVIDED BYINVESTING|||ACTIVITIES||||(158,598)|(166,895)|
|CASH FLOWS FROM FINANCING|ACTIVITIES:||||||||
|Net change
in cash and
short term deposits|||||(investment||(14,293)|(125,760)|
|assets)|||||||||
|NET CASH FLOWS PROVIDED BY/(USED IN)|||||||(14293)|(125,760)|
|FINANCING
ACTIVITIES|||||||||
|Change
in cash and cash equivalents||||in the reporting|||833,140|1,005,261|
|period|||||||||
|Cash
and
cash
equivalents
at|the||beginning|||of the|1,048,822|43,561|
|reporting
period|||||||||
|Cash
and
cash
equivalents
at the end||||of the||reporting|1,881,962|1,048,822|
|period (Note 23)|||||||||
|Depreciation/amortisation|Depreciation/amortisation|oftangible and intangible|fixed assets|256,400|296,811|
|---|---|---|---|---|---|
|Investment
income|received|||(103,752)|(45,440)|
|(Increase)/decrease|in|debtors||(170,691)|588,866|
|Increase/(decrease)|in|creditors||(195,784)|(742,840)|
|Decrease/(increase)|in|stocks||49,772|52,981|
|NET CASH USED|IN OPERATING ACTIVITIES (PAGE 49)|||1,006,031|1,297,916|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|4a.Trading Oper|ations|in Subsidi|ary|ary||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|The charity has a|trading|subsidiary,|Tenovus Trading||Limited, company|||number 01157332,a company||||
|limited by guarantee
which is incorporated||||in the UK. The subsidiary|||sells||greeting cards, calendars|and||
|other promotional|goods,|and covenants||all its taxable|profits|to Tenovus||Cancer Care, The subsidiary|||also|
|rents mobile units|from the charity for its|||own use. A summary||ofits trading|||results follows.|||
||||||||||2022||2021|
|INCOME &EXPENDITURE ACCOUNT|||||||||||E|
|Turnover||||||||||||
|New Goods|||||||||111,714||106,425|
|Mobile Unit|||||||||135,162||124,024|
||||||||||246,876||230,449|
|Net operating
expenses||new goods|||||||(133,495)|(145,821)||
|Net operating expenses||mobile unit|||||||(71,168)||(83,833)|
|Operating
surplus|||||||||42,213||795|
|Prior year funds|||||||||||2,500|
|Amount covenanted
to Tenovus Cancer Care|||||||||(42,213)||(3,295)|
|Retained
in subsidiary||||||||||||
|A summary
of its|aggregate assets,||liabilities and funds is as follows:|||||||||
|Assets|||||||||202,457||194,174|
|Liabilities|||||||||(195,106)|(186,823)||
|Funds|||||||||7,351||7,351|
##
|5.Investment
In|co|me|||||||
|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|2022|2021|
||||||E|E|E|E|
|Dividend
income|||||103,742||103,742|45,436|
|Interest receivable|||||10||10|4|
||||||103,752||103,752|45,440|
|6.Expenditure|for Raising Donations||||Legacies and Other||||
||||||Unrestricted|Restricted|2022|2021|
||||||E|E|E|E|
|Donations
&Gifts||(6a)|||862,226|5,522|867,748|784,158|
|Donated goods|and services (6b)||||113,258||113,258|153,453|
|Legacies and Trusts|||||146,404||146,404|200,738|
|Investment
Management|||Costs||26,790||26,790|20,345|
||||||1,148,678|5,522|1,154,200|1,158,694|
|6a.Donations|and Gifts||||Unrestricted|Restricted|2022|2021|
||||||E|E|E|E|
|Staff &other related costs|||||291,182|1,163|292,345|357,766|
|Other overhead|costs||||80,895||80,895|43,557|
|Support costs|||||490,149|4,359|494,508|382,835|
||||||862,226|5,522|867,748|784,158|
|6b. Donated Goods &|||Services||Unrestricted|Restricted|2022|2021|
||||||E|E|E|E|
|Publicity|||||88,258||88,258|91,211|
|Mobile
Support||Unit|equipment|&|25,000||25,000|25,000|
|services|||||||||
|Rent||||||||36,875|
|Goods &Services||||||||367|
||||||113,258||113,258|153,453|
|.Retail and Other Trading A|ctivities||||
|---|---|---|---|---|
|Retail Operations|||2022|2021|
||||K|6|
|Retail shops costs (7a)|||4,188,495|3,576,474|
|Cost otsales on new goods (subsidiary)||(note 4a)|133,495|145,821|
||||4,321,990|3,722,295|
|Other Trading Activities|||||
|Event costs|||79,233|95,874|
|Lottery|||61,902|81,606|
|Mobile Units costs (subsidiaiy)|(note 4a)||71,168|83,833|
||||212,303|261,313|
||||4,534,293|3,983,608|
|||Unrestricted|Restricted|2022|2021|
|---|---|---|---|---|---|
|||Funds|Funds|||
|||6|E|||
|Ta.Retail Shop Costs||||||
|Staff &other related costs||1,944,576|18,573|1,963,149|1,835,739|
|Rent, rates &insurance||1,045,113||1,045,113|973,956|
|Other costs||300,188||300,188|134,856|
|Utilities||278,893||278,893|82,230|
|Repairs &renewals||94,681||94,681|15,828|
|Depreciation||13,563|4,958|18,521|15,937|
|Support costs||483,367|4,583|487,950|517,928|
|||4,160,381|28,114|4,188I495|3,576,474|
|Cost ofCharitable|Activities|||||
|||Unrestricted|Restricted|2022|2021|
|||Funds|Funds|||
|||E|E|||
|Ba.Benefit Advisors||||||
|Staff &other related|costs|90,066|42,018|132,084|209,524|
|Direct overheads||10,494|3,444|13,938|71,515|
|Support costs (9)||127,518|15,561|143,079|45,863|
|||228,078|61,023|289,101|326,902|
|||Unrestricted|Restricted|2022|2021|
|||Funds|Funds|||
|||E|6|||
|Bb.Counselling||||||
|Staff &other related|costs|1,184|39,712|40,896||
|Direct overheads|||1,324|1,324||
|Support costs (9)||||||
|||1,184|41,036|42,220||
##
##
|Notes to the fi|nanc|ial statements
fo|r the year ended 31 March 2022 —|r the year ended 31 March 2022 —|c|ontinued|||
|---|---|---|---|---|---|---|---|---|
||||Unrestricted
Restricted|||2022||2021|
||||Funds|Funds|||||
||||6|6|||||
|Bc.Support Line|||||||||
|Staff 8 other related||costs|61,505|26,004||87,509|82,997||
|Direct overheads|||7,320|3,520||10,840|10,709||
|Support costs (9)|||46,089|5,174||51,263|45,864||
||||114,914|34,698||149,612|139,570||
||||Unrestricted
Restricted|||2022||2021|
||||Funds|Funds|||||
||||6|8|||||
|Bd. Mobile Support||Units|||||||
|Staff &other related||costs|161,479|26,014|187,493||254,925||
|Direct overheads|||242,545|128,596|371,141||289,333||
|Support costs (9)|||165,755|1,478|167,233||119,572||
||||569,779|156,088|725,867||663,830||
|Be.Sing with Us|Support Groups||||||||
||||Unrestricted|Restricted||2022||2021|
||||Funds|Funds||6|||
||||6|6|||||
|Staif costs|||117,634|30,232||147,866||227,388|
|Direct overhead|costs||40,453|5,407||45,860||59,236|
|Support costs (9)|||134,926|8,153||143,079||193,281|
||||293,013|43,792||336,805||479,905|
|Bf.Research, Policy||&Insight|||||||
||||Unrestricted|Restricted||2022||2021|
||||Funds|Funds||6||8|
|Research grants|||(41,191)|||(41,191)||(4,243)|
|Staff costs|||39,210|13,330||52,540||137,669|
|Direct overhead|costs||22,504|||22,504||13,514|
|Support costs (9)|||76,000|5,092||81,092||91,701|
||||96,523|18,422||114,945||238,641|
##
||||||||||
|---|---|---|---|---|---|---|---|---|
|9.Support Costs||||||||Total|
||||Other|overhead|Staffcosts||Total2922|2021|
|||||E|E||E||
|Retail &Subsidiaries||||214,451|304,879||519,330|563,463|
|Costs ofRaising Funds||||204,544|289,964||494,508|414,408|
|Benefit Advisors||||59,214|83,865||143,079|45,863|
|Support Line||||21,244|30,019||51,263|45,864|
|Mobile Support
Units||||69,203|98,030||167,233|119,572|
|Sing with Us Support Groups||||59,214|83,865||143,079|193,281|
|Research, Policy & Insight||||33,624|47,468||81,092|91,701|
|Counselling|||||||||
|||||661,494|938,090||1,599,584|1,474,152|
|10.Staff Costs And Trustees'||Remuneration|||||||
||||||||2022|2021|
||||||||E|E|
|Wages &salaries||||||3,541,267||3,671,848|
|Redundancy
&termination|payments||||||26,942|84,336|
|Social security costs|||||||269,787|261,989|
|Other pension costs (note 24)|||||||141,567|159,243|
|||||||3,979,563||4,177,416|
|The number ofhigher paid employees|||was as follows:||||||
||||||||2022|2021|
||||||||Number|Number|
|F60,001 - F70,000|||||||||
|F70,001 - E80,000|||||||||
|E80,001 - E90,000|||||||||
|E100,001 - E110,000|||||||||
|The number ofhigher paid employees|||for whom retirement||benefits are|accruing:|||
||||||||2022|2021|
||||||||Number|Number|
|E60,001 - F70,000|||||||||
|E70,001 - E80,000|||||||||
|E80,001 - E90,000|||||||||
|F100,001 - E110,000|||||||||
##
##
|ension
contributions
for higher paid employees|are as follows:||
|---|---|---|
||2022|2021|
||Number|Number|
|f60,001 - 670,000|4,427|8,295|
|L70,001 - 280,000|12,286||
|E80,001 - 690,000||6,145|
|f100,001 - F110,000|7,140||
##
##
|11.Staff Numbers|||||||
|---|---|---|---|---|---|---|
||||||2022|2021|
||||||Number|Number|
|Average
number ofemployees
(full time|equivalent)||||163||
|Benefit Advisors —costs allocated to statement
of||financial|||||
|activities —benefit advisor costs|||||||
|Support
Line —costs allocated to statement|offinancial||activities—||||
|support
line costs|||||||
|Counselling
-costs allocated to statement|offinancial activities-||||||
|counselling
costs|||||||
|Mobile Units —costs allocated to statement|offinancial activities—||||||
|mobile unit cost|||||||
|Sing with Us Support Groups- costs allocated to||statement||of|||
|financial
activities —Sing with Us support groups|||||||
|Research, Policy & Insight —allocated to statement||offinancial|||||
|activities —research,
policy & insight costs|||||||
|Income Generation
Department-
allocated
financial activities —cost ofraising funds|to statement||of||14|12|
|Head Office —allocated to statement
offinancial
activities -support|||||22|17|
|costs|||||||
|Marketing
& Communication
—allocated
to statement|||of financial||||
|activities —support costs|||||||
|Shops —allocated
to the statement
of financial
costs||activities||—retail|100|97|
||||||163|154|
|The incoming
resources for the year are|The incoming
resources for the year are|The incoming
resources for the year are|made up as||follows:|2022|2021|
|---|---|---|---|---|---|---|---|
|||||||E|E|
|Income generated
by parent charitable||company||||8,270,253|7,908,239|
|Expenditure
by parent charitable|company|||||(7,142,480)|(6,761,496)|
|Share of incoming
resources generated|||by subsidiary||in year|42,313|795|
|and covenanted
to this company|(Note|4a)||||||
|||||||1,170,086|1,147,538|
|13.Net Incoming Resources||||||||
|Net incoming
resources
for the year|||is stated|after||2022|2021|
|charging:||||||6|6|
|Gift Aid income||||||291,618|69,036|
|Depreciation
oftangibles||||||223,859|262,479|
|Amoitisation
ofIntangibles||||||32,541|34,332|
|Auditors'
remuneration
—audit fee||||||12,604|12,570|
|Land and buildings
operating
lease costs||||||1,034,877|1,063,723|
|Other operating
lease costs||||||22,315|32,768|
|Gain/(loss)
on disposal oftangible|fixed|assets||||46,385|(31,282)|
|CD
~
Dl
o
h)
h)O|Z
(D
CO
g
(
C
CD|QI
Cl
IQ
hl
IV|0
(
ID
C
CI
N|Col
c
Cl
hl
lO
IO
O
Cs(
Vl
(0
Ol|Cf
8
Cl
N4S
(0|Xl
Cl0
DlNN
QI
(D0.|0.
Dl'00
N
N|m
3
N
(D0.0
(0
((
Ql(0|0
Dl
(2
Cl
'C
Cl
Dl
CD|h)
Cl
IQ
Ql
(0
Q(|O
CI'0
0
Cl
lil
0|CD
c
0
hl
CI
hl
(0
CD
(0
(0|Cf
(D
(D4
(0|0
O
DlNN
Cl0.|O
N
0
N
N
N
(0~
I|0
O
O0|IQ
CI
h)
Ol|O0
N|303I3
Cl
N|Cl
Dl
N
Cl
04
N
0'0|0
Dl
CI0'
0
Zl
0X4
DI
ClI'
I
O|X0
CI
Cl
0
Cl
Dl
Cl
ITI
(0
N'|0 0 0
0 0
Dl
mS
CC
4g
Dl
C(KR8
Dai
RD(O
Dl O
3 O
QO
IQ 0
gt|0 0 0
0 0
Dl
mS
CC
4g
Dl
C(KR8
Dai
RD(O
Dl O
3 O
QO
IQ 0
gt|0 0 0
0 0
Dl
mS
CC
4g
Dl
C(KR8
Dai
RD(O
Dl O
3 O
QO
IQ 0
gt|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||||||||||IID|||||
||||Ol
(0||||||CI
Ql||||||||||I
O
(D
N|0|0
CI
Re|||||
|||||||||||||||||||||ll|OI|0||||
||||IQ
(0|||||Cl(0
Ql
Ql||S
Cl||tel
OI|||Cl
QI
Ql
Ql||IQ
hl
Ol
Cll
00||g
(N|C
N
Cl
9(|4|4
Dl||||
|||||||||||||||||||||||CI||||
||||Ql
Col
Ol|CI
Ql
lO
DI
CI||||Ql
(0
QI|O
GJ|||(0
Ol
(0
Ql
Ol|||||(0
O
CO
OI
VI|||I
m
J3C'63
(D||DO
CI
M
I00||||
||||||||||||||||||||c$ 3
CC|||C
Cl
CL||||
||||(0
(0
IQ|(0
IV
CI
Ql||||VI(0
CD
00V||||CO
Vl
Vl
DI
Ol|||Ql
Ql
CI||IQ
(0
Vl
OD
V||N
H|(D
CII||||||
|||||||||||||||||||||0||||||
||||||||||||||||||hl|||||||||
||Ql|||||||||||||||||||||||||
||||||||||||||||||hl||I|||||||
||Ql
Co|||||||||||CI|||||CI
Cl|||||||||
|||||||||||||IO|||||VI|||0||||||
|||||Ql
Ql
00||CI
(0
M||||||Ol(0
(0
(0||CD||0(
CD
Cl
CD|OD
CO
VI
Ol
CI
IO|||I||||||
##
##
|Charity &Group|||||||
|---|---|---|---|---|---|---|
||||Software|TOTAL|||
||||6|8|||
|Acquisition
Cost|||||||
|At 1 April 2021|||150,316|150,316|||
|Additions|||62,553|62,553|||
|Disposals|||(25,100)|(25,100)|||
|At 31 March 2022|||187,769|187,769|||
|Amortisation|||||||
|At 1 April 2021|||74,048|74,048|||
|Charge for the year|||32,541|32,541|||
|Eliminated
on disposal|||(25,100)|(25,100)|||
|At 31 March 2022|||81,489|81,489|||
|Net Book Value|at|31|106,280|106,280|||
|March 2022|||||||
|Net Book Value|at|31|76,268|76g68|||
|March 2021|||||||
|16.Fixed Asset Investments|||||||
|Group &Charity|||||2022|2021|
||||||6|6|
|Fair value at 1 April 2021|||||4,022,759|2,940,386|
|Less: disposals at opening|||fair value||(589,884)|(1,648,757)|
|Add: acquisitions|at|cost|||928,852|2,234,127|
|Net unrealised
investment|||gains/(losses)||233,763|371,243|
|Increase/(decrease)||in cash as held as part of investment|||14,293|125,760|
|portfolio|||||||
|Fair value at 31 March 2022|||||4,609,783|4,022,759|
##
##
|ended|||||
|---|---|---|---|---|
|Split by:|||||
||||2022|2021|
||||E|E|
|Fixed Asset Investments|||4,609,783|4,022,759|
|Represented
by:|||||
|Quoted
UK Investments|||||
|Fixed Interest Stock,|UK Government|||55,428|
|Corporate
bond and bond funds|||577,190|391,328|
|Equities|||3,086,279|2,754,055|
|Other Investments|||716,225|670,609|
|Cash
& Short-Term|bonds|held as part of investment|230,089|151,339|
|porffolio|||||
|Fair value at 31 March|2022||4,609,783|4,022,759|
|Cost at 31 March 2022|||3,879,089|3,492,675|
##
##
##
||||Group|Group|Charity||
|---|---|---|---|---|---|---|
||||2022|2021|2022|2021|
||||E|E|E|E|
|Greeting|cards &merchandise||9,017|58,789|||
||||9,017|58,789|||
|18.Debtors|||||||
|||Group|||Charity||
|||2022||2021|2022|2021|
|Amounts|falling due within one year.|E||E|E|E|
|Trade debtors||100,422||130,028|79,950|93,952|
|Amount|due from subsidiaries||||137,002|133,746|
|Other debtors||127,803||14,763|127,803|14,762|
|Prepayments||224,603||363,281|224,511|363,240|
|Accrued|Income|435,282||209,347|435,282|199,347|
|||888,110||717,419|1,004,548|805,047|
|19.Creditors|||||||
|||Group|||Charity||
|||2022||2021|2022|2021|
|Amounts|falling due within one year:|E||E|E|E|
|Trade creditors||230,675||99,163|230,675|99,110|
|Accruals||427,913||624,911|424,481|621,941|
|Deferred|income (19a)|142,452||133,485|89,280|96,933|
|Other creditors||281,858||280,148|280,358|266,646|
|||1,082,898|1,137,707||1,024,794|1,084,630|
||||Group||Charity||
|---|---|---|---|---|---|---|
|19aDeferred Income|||2022|2021|2022|2021|
||||f|6|6||
|Opening|Balance||133,485|122,790|96,933|46,108|
|Received|in the year||250,680|225,058|232,388|197,578|
|Released|in the year||(241,713)|(214,363)|(240,041)|(146,753)|
|Closing Balance|||142,452|133,485|89,280|96,933|
|19bCreditors Amounts||Falling Due After One Year|||||
||||Group||Charity||
||||2022|2021|2022|2021|
||||6|K|E|E|
|Other creditors|||162,449|303,712|162,449|303,712|
||||162,449|303,712|162,449|303,712|
##
|20.Financial
Instru|ments|||||||
|---|---|---|---|---|---|---|---|
|||||Group||Charity||
|||||2022|2021|2022|2021|
|||||R|6|6|6|
|Financial assets measured||at|fair|||||
|value||||||||
|Investments||||4,609,783|4,022,759|4,609,783|4,022,759|
|||||4,609,783|4,022,759|4,609,783|4,022,759|
|Financial assets measured||at||||||
|amortised cost||||||||
|Trade debtors||||100,422|130,028|79,950|93,952|
|Other debtor transactions||||563,085|224,110|700,087|347,855|
|Cash||||1,881,962|1,048,822|1,709,086|959,555|
|||||2,545,469|1,402,960|2,489,123|1,401,362|
|Financial liabilities|measured||at|||||
|amortised cost||||||||
|Trade creditors||||230,675|99,163|230,675|99,110|
|Other creditor transactions||||872,220|1,208,771|867,288|1,192,299|
|||||1,102,895|1,307,934|1,097,963|1,291,409|
##
|21.Funds||||||||
|---|---|---|---|---|---|---|---|
|||Balance at|income|Expenditure|Investment|Transfers|Balance at|
|||1 April 2021|||gains/
losses|between
Funds|31
Ilarch|
|||||8|6|6|2022|
||||||||E|
|Unrestricted||||||||
|General
Fund||3,881,809|7,568,611|(6,481,674)|260,099|(94,827)|5,134,018|
|Designated
Funds||||||||
|Development
of||116,520||(61,817)|||54,703|
|Sustainable
Income||||||||
|Streams
Fund||||||||
|Office Move Fund||40,000||(37,220)||62,220|65,000|
|Property
Upgrade||140,000||(48,119)||(91,881)||
|Fund||||||||
|Mobile Units Fund||150,000||(14,190)|||135,810|
|Community
insight||200,000|||||200,000|
|and Emotional
support||||||||
|Increased
Digitalisation
across||150,000||(101,643)||50,000|98,357|
|the Charity
Fund||||||||
|Lung Cancer||||||||
|Screening
Fund||100,000|100,000||||200,000|
|Retail Improvement||||||||
|Programme
Less Survivable
Cancers Fund||200,000||(9,022)||139,022
100,000|330,000
100,000|
|End of Life Fund||||||100,000|100,000|
|Total Unrestricted||4,978,329|7,668,611|(6,753,685)|260,099|264,534|6,417,888|
|Restricted||||||||
|Equipment
Fund||17,765|||||17,765|
|Mobile Units Capital||||||||
|Fund||863,438||(128,596)|46,358|(126,671)|654,529|
|Mobile Units Running||||||||
|Costs Fund||12,977|21,364|(26,018)||5,000|13,323|
|Research
Fund|||113,327|||(85,591)|27,736|
|Retail Fund||25,144||(4,958)|||20,186|
|Support Services||||||||
|Fund||109,252|394,177|(178,847)||(15,059)|309,523|
|Support Groups Fund||11,839|36,262|(13,764)|||34,337|
|Job Retention Scheme|||36,512|(36,512)||||
|Fund||||||||
|Total Restricted||1,040,415|601,642|(388,695)|46,358|(222,321)|1,077,399|
|Total Charity||6,018,744|8,270,253|(7,142,380)|306,457|42,213|7,495,287|
|Total Subsidiary|(4a)|7,351|246,876|(204,663)||(42,213)|7,351|
|Total Group||6,026,095|8,517,129|(7,347,043)|306,457||7,502,638|
##
##
##
##
##
##
##
|||Balance at|Income|Expenditure|Investment|Transfers|Balance at|
|---|---|---|---|---|---|---|---|
|||1 April 2020|||gains/
losses|between
Funds|31
March|
|||||E|E||2021|
||||||||E|
|Unrestricted||||||||
|General
Fund||2,676,645|6,201,137|(4,943,462)|673,479|(725,990)|3,881,809|
|Designated
Funds||||||||
|Development
of||120,857||(4,337)|||116,520|
|Sustainable
Income||||||||
|Streams Fund||||||||
|Development
of||25,057||(25,057)||||
|Charitable
Activity||||||||
|Office Move Fund||27,853||(20,691)||32,838|40,000|
|Property
Upgrade||90,000||||50,000|140,000|
|Fund||||||||
|Mobile Units|||150,000||||150,000|
|Community
insight||||||200,000|200,000|
|and Emotional
support||||||||
|Increased
Digitalisation
across||||||150,000|150,000|
|the Charity||||||||
|Lung Cancer
Screening
Fund||||||100,000|100,000|
|Retail Improvement||||||||
|Programme||||||200,000|200,000|
|Total Unrestricted||2,940,412|6,351,137|(4,993,547)|673,479|6,848|4,978,329|
|Restricted||||||||
|Equipment
Fund||13,855|3,910||||17,765|
|Mobile Units Capital||||||||
|Fund||1,002,590||(139,152)|||863,438|
|Mobile Units Running||||||||
|Costs Fund||56,849|48,773|(91,675)||(970)|12,977|
|Research Fund|||6,000|||(6,000)||
|Retail Fund|||26,344|(1,200)|||25,144|
|Support Services||||||||
|Fund||25,143|197,478|(110,376)|(2,993)||109,252|
|Support Groups Fund||62,853|24,585|(74,047)||(1,552)|11,839|
|Velindre
Fund||96,518||(101,487)||4,969||
|Job Retention Scheme|||1,250,012|(1,250,012)||||
|Fund||||||||
|Total Restricted||1,257,808|1,557,102|(1,767,949)|(2,993)|(3,553)|1,040,415|
|Total Charity||4,198,220|7,908,239|(6,761,496)|670,486|3,295|6,018,744|
|Total Subsidiary|(4a)|9,851|230,449|(229,654)||(3,295)|7,351|
|Total Group||4,208,071|8,138,688|(6,991,150)|670,486||6,026,095|
##
##
||General Funds|General Funds|Designated|Restricted Funds|Restricted Funds|Total|
|---|---|---|---|---|---|---|
||||Funds|||31 March 2022|
||||6||f|6|
|Charity|||||||
|Fixed/||684,397|||674,716|1,359,113|
|Intangible|||||||
|assets|||||||
|Investments||4,609,783||||4,609,783|
|Net assets/||(160,162)|1,283,870||402,683|1,526,391|
|(liabilities)|||||||
|||5,134,018|1,283,870||1,077,399|7,495,287|
|Group|||||||
|Fixed/||684,397|||674,716|1,359,113|
|Intangible|||||||
|assets|||||||
|Investments||4,609,783||||4,609,783|
|Net current||(152,811)|1,283,870||402,683|1,533,742|
|assets/|||||||
|(liabilities)|||||||
|||5,141,369|1,283,870||1,077,399|7,502,638|
|23.Analysis of|Net Funds||||||
||||1 April|2021|Cash flows|31 March|
|||||||2022|
|||||||6|
|Net cash analysed||in the|||||
|balance sheet|||||||
|Cash at bank and in hand|||1,048,822||833,140|1,881,962|
|Net funds|||1,048,822||833,140|1,881,962|
##
##
##
##
##
##
##
##
|expenditure
account|and s|tatement|of recognised|||||
|---|---|---|---|---|---|---|---|
|||Note|Unrestricted|Restricted||Total 2021|Total 2020|
||||Funds 2021|Funds|2021|||
||||6|E||||
|INCOME &||||||||
|ENDOWMENTS
FROM:||||||||
|Donations
&Legacies|||3,315,498|245,159||3,560,657|2,657,701|
|Charitable
Activities|||||61,931|61,931|178,205|
|Total Fundraising|||3,315,498|307,090||3,622,588|2,835,906|
|Income||||||||
|Expenditure||||||||
|Raising funds—|||969,884|188,810||1,158,694|1,019,293|
|donations
&legacies||||||||
|Total Fundraising|||969,884|188,810||1,158,694|1,019,293|
|Expenditure||||||||
|Fundraising|||2,345,614|118,280||2,463,894|1,816,613|
|Contribution||||||||
|Job Retention Scheme||||1,250,012||1,250,012||
|Covid Retail Grants|||1,032,143|||1,032,143||
|Investment
income|||45,440|||45,440|115,112|
|Other income|||||||1,350|
|Total Contribution|from||3,423,197|1,368,292||4,791,489|1,933,075|
|Income &Endowments||||||||
|Retail Operations|||1,585,340|||1,585,340|5,206,993|
|Trading
Income||||||||
|Retail Operations|||2,896,589|825,706||3,722,295|4,696,610|
|Trading
Expenditure||||||||
|Contribution
from|||(1,311,249)|(825,706)||(2,136,955)|510,383|
|Retail Operations||||||||
|Other Trading Activities|||603,165|||603,165|527,906|
|Income||||||||
|Other Trading Activities|||261,313|||261,313|466,753|
|Expenditure||||||||
|Contribution
from|||341,852|||341,852|61,153|
|Other Activities||||||||
|Total Contribution|from||(969,397)|(825,706)||(1,795,103)|571,536|
|Trading Activities||||||||
|Year Endin
31"March 20|Year Endin
31"March 20|22|22||||||80||
|---|---|---|---|---|---|---|---|---|---|---|
|Consolidated
Statement||of Financial||Activities
for the year ended 31||March|2021 (incorporating||income|and|
|expenditure
account|and|statement|of|recognised
gains and losses) continued.|||||||
|Net income available|for|||2,453,800|542,586|2,996,386||2,504,611|||
|Charitable
Activities|||||||||||
|Charitable
Expenditure||8|||||||||
|Grants to research||Sa||132,375|36,813||169,188||740,421||
|or anisations|||||||||||
|Patient Services||Sb||620,815|509,487|1,130,302||1,920,627|||
|Sing with Us Support||Sc||281,953|197,952||479,905||624,363||
|Grou s|||||||||||
|Policy &Campaigns||8(j||60,272|9,181||69,453||313,173||
|Total Charitable||||1,095,415|753,433|1,848,848||3,598,584|||
|Ex enditure|||||||||||
|Net income before||||1,358,385|(210,847)|1,147,538||(1,093,973)|||
|(loss) /gain on|||||||||||
|investments|||||||||||
|Represented
by|||||||||||
|Total Income||||6,581,586|1,557,102|8,138,688||8,687,267|||
|Total Expenditure||||5,223,201|1,767,949|6,991,150||9,781,240|||
|Net||||1,358,385|(210,847)|1,147,538||(1,093,973)|||
|income/expenditure|||||||||||
|before (loss) /gain on|||||||||||
|investments/fixed|||||||||||
|assets|||||||||||
|Net (loss) /gain on||16||701,768|||701,768|(284,829)|||
|investments|||||||||||
|Transfer between||||3,553|(3,553)||||||
|funds|||||||||||
|Losses on disposal|of|13||(28,289)|(2,993)||(31,282)||(534)||
|fixed assets|||||||||||
|Net movement
in funds||||2,035,417|(217,393)|1,818,024||(1,379,336)|||
|Reconciliation
offunds||21|||||||||
|Funds brought
forward at||||2,950,263|1,257,808|4,208,071||5,587,407|||
|1 April 2020|||||||||||
|Total funds carried||21||4,985,680|1,040,415|6,026,095||4,208,071|||
|forward at 31 March|||||||||||
|2021|||||||||||
##
##
##
##
##
##